​
Thanks for getting in touch.
We’ve received your inquiry and will follow up by email.
Your form wasn’t submitted. Please try again or email office@bioptic.io.
​
Thanks for your request.
We’ll send the sample reports to the email address you provided. We’ll email the samples within one business day.
Your form wasn’t submitted. Please try again or email office@bioptic.io.

Blog

How the work actually goes: what pharma and investors ask us for, what our agents find that a search misses, and how we check whether an answer holds up.

10 Jun 2026

BIOPTIC B1 Featured in Peer-Reviewed Cell Chemical Biology Paper on Friedreich's Ataxia

Many companies are announcing AI-powered virtual screening for drug discovery. Very few are publishing peer-reviewed research showing how the compounds those systems identify actually perform in human disease models.

Read more
BIOPTIC B1 Featured in Peer-Reviewed Cell Chemical Biology Paper on Friedreich's Ataxia

19 Mar 2026

Bioptic Agent Outperforms Claude, GPT-5, and Gemini at Drug Asset Scouting — New Paper

Read more
Bioptic Agent Outperforms Claude, GPT-5, and Gemini at Drug Asset Scouting — New Paper

All posts

26 Jan 2026

BIOPTIC Vision for AI-Native Pharma: Keynote Speech at MCT 2026

What we shared at Machines Can Think Summit 2026

Read more
BIOPTIC Vision for AI-Native Pharma: Keynote Speech at MCT 2026

22 Jan 2026

AAAI 2026: Bioptic’s Agentic Due Diligence Paper Receives an Award

Peer-reviewed, deployed, and now award-winning: our AI for drug asset due diligence took the AAAI 2026 Deployed Application Award in Singapore.

Read more
AAAI 2026: Bioptic’s Agentic Due Diligence Paper Receives an Award
Archive

Writing from our discovery years, 2023—2025

Models, competitions and partnerships from before we moved to the commercial side. Kept because it is where the methods came from — not because it is what we sell.

Tell us about your project

Tell us about your research question and deadline. We’ll follow up to discuss the scope, deliverables, and timing.

Name

Company

Work email

Country

Phone number
Project details (optional)
Thanks for getting in touch.
We’ve received your inquiry and will follow up by email.
Your form wasn’t submitted. Please try again or email office@bioptic.io.